- Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells.
- Zhang B, Lyu J, Yang EJ, Liu Y, Wu C, Pardeshi L, Tan K, Chen Q, Xu X, Deng CX, Shim JS.
- Acta Pharm Sin B. 2020 Apr;10(4):615-627. doi: 10.1016/j.apsb.2019.08.008. Epub 2019 Sep 5.
- PMID: 32322466
- PubMed abstract